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966 The Journal of Thoracic and CardioWhen I was still a student in the late 1960s and started following the callfor cardiovascular pathology, the job was restricted mostly to autopsy.This discipline was the Cinderella within the large family of anatomic
pathology, and the reason was that it dealt only with cadavers.
Cardiac surgery was just starting, and there was high operative mortality. The
cardiovascular pathologist was asked to perform autopsies on surgical fatalities,
bearing witness to limitations in medical knowledge. Cardiopulmonary bypass and
cardiac arrest allowed the surgeons to open the heart and correct the defects, being
still unaware of elementary morphologic notions, such as the topography of the
conduction system. Most of the septal defects first operated on at the Mayo Clinic
with the use of a cardiopulmonary bypass machine were weaned off the pump with
atrioventricular block.1
Operable cardiac diseases consist of gross structural defects, and clearly the mission
of the pathologist was to support the clinicians and surgeons by transferring the
postmortem information into knowledge of clinical and surgical anatomy to improve the
diagnosis and treatment for the benefit of the patient. The anatomic theater was still the
place mors ubi gaudet succurrere vitae (where death enjoys to help life).2
It soon became evident that the cardiologist, the cardiac surgeon, and the
cardiovascular pathologist should possess a similar cultural background, despite
different professional duties. The catheterization laboratory, the surgical theater, and
the autopsy room were places where the same teaching and language for fruitful
clinicopathologic correlations were applied.3
After improvements in anesthesiology and myocardial-cerebral protection during
cardiac arrest, which rendered operations feasible in neonates,4 a sound knowledge
of the anatomy of complex congenital heart disease appeared to be a prerequisite for
optimizing clinical diagnosis and improving surgical repair. Implementation of a
cardiac registry of congenital heart disease specimens allowed the study of the
whole anatomic spectrum of various defects. The segmental approach (atria, ven-
tricles, and great arteries) was introduced as the best way to clear up the difficulty
of diagnosing complex congenital heart diseases, with the aim of reconstruction by
means of operatively separated pulmonary and systemic circulations in a right
sequential manner.5 The identification of the precise course of the conduction
system through histologic serial sections (Figure 1) virtually removed all the risks
of atrioventricular block during closure of septal defects by guiding the hand of the
surgeon in suturing the patch.
The early occurrence of pulmonary vascular disease was found to jeopardize the
surgical repair of congenital heart disease with septal defects (Figure 2) and to
suggest the need to plan the time of operation within the first year of life. It is quite
rewarding to realize that thanks to the improvement of diagnostic and surgical
expertise with the help of the pathologist, the mortality for repair of congenital heart
disease, including quite complex forms, such as univentricular hearts, decreased
drastically with time.
Any tissue resected during cardiac surgery started undergoing routine histologic
analysis, thus opening the era of cardiovascular surgical pathology. Valves, vessels,
venous or arterial grafts, pericardium, and tumors were submitted systematically to
a precise microscopic diagnosis, an essential step in establishing the nosography and
epidemiology of operable cardiovascular disease (Figure 3).







LThe increasing use of valvular prostheses, with an intrin-
sic propensity toward structural failure, required a novel
skill. Bioprosthetic valves were found to have limited du-
rability, with a half-life of only 8 to 10 years. Calcification
proved to be the main cause of failure, with cusp stiffening,
disruption, or both.6 In vivo animal studies and in vitro
experiments were carried out to test antimineralization
agents, with the aim of introducing new devices with a 5- to
7-year increase of half-life in clinical practice.7
In the past there was a common quote, “The pathologist
knows everything, but too late.” This limitation changed
abruptly in the cardiovascular field with the introduction of
the endomyocardial biopsy.8 Endomyocardial biopsy is to-
day the gold standard for diagnosis of myocarditis, giving
the cardiovascular pathologist the final word.
The pivotal role of the cardiovascular pathologist was
further enhanced by the beginning of a cardiac transplanta-
tion program, which requires the use of endomyocardial
biopsy for rejection monitoring. The study of heart speci-
mens resected at the time of transplantation resulted in an
extraordinary opportunity for research with the discovery of
new morbid entities, such as requiring a new World Health
Organization classification of cardiomyopathies.9
On the autopsy side, a new demand for cardiovascular
pathology came from the amazing occurrence of sudden
death, even in young people or athletes collapsing on the
playground. The concept that the heart might stop suddenly
because of ventricular fibrillation in the absence of an
ischemic milieu was a revolutionary step forward for the
pathologist. We soon realized that the working ventricular
myocardium itself might be the substrate of life-threatening
arrhythmias, despite the integrity of the conduction system
and the coronary arteries. Arrhythmogenic right ventricular
cardiomyopathy, which was discovered at autopsy to be the
major cause of sudden death in the young,10 represented an
alarming instance insofar as fibrofatty replacement of the
right ventricular free wall might trigger lethal tachyarrhyth-
mias during effort through reentrant mechanisms, even in
the setting of a normal left ventricle and conduction system.
The traditional tools of the pathologist are the eyes at
autopsy for gross dissection and the light microscope for
histologic examination. Magnification power increased sig-
nificantly with electron microscopy, allowing morphologic
investigation at the subcellular level. However, there are
offending organisms or structural defects that escape ultra-
structural imaging, emphasizing the limits of traditional
morphology. The discovery of new molecular biology tools,
such as in situ hybridization and the polymerase chain
reaction (PCR), as well as gene cloning and sequencing,
opened extraordinary avenues for new insight deep in the
cell and nuclear pathophysiology, as well as in the genes
and coded proteins. The collaboration with clinicians was
The Journal of Thoraciextended to basic scientists, and this policy has been re-
warding insofar as in 15 years it has been possible to move
from the first postmortem observation of familiar arrhyth-
mogenic right ventricular cardiomyopathy to the discovery
of the culprit gene.11
The use of PCR or reverse transcriptase PCR, able to
amplify DNA or RNA by up to 1 billion copies, was a
powerful weapon in detecting viral particles, which were
found in up to 50% of endomyocardial biopsy specimens
from patients with myocarditis. DNA viruses, like adeno-
virus, were found to be cardiotropic as much as RNA
enterovirus. PCR is now an essential tool in endomyocardial
biopsy evaluation to achieve a gold standard for diagnosis.
Up to 10% of young people dying suddenly present with
a normal heart (mors sine materia). For the pathologist, it
was frustrating and difficult to accept that patients who die
Figure 1. The course of atrioventricular conduction tissue in
complete atrioventricular canal. The dotted line indicates how to
insert the surgical patch so as to avoid atrioventricular block.suddenly had a normal heart, even after extensive morpho-





Llogic examination including the conduction system. Molec-
ular genetics demonstrated that many of these cases are
ascribable to genes encoding defective proteins, receptors,
or both of cell–sarcoplasmic reticulum membranes, where
ion channels are located. Clearly, these defects are beyond
the magnification power of any microscope. A mutation of
a single base might account for an altered coded protein
with only one different amino acid (Figure 4), enough to
Figure 2. Pulmonary vascular disease in congenital he
feature of the pulmonary artery on the postmortem an
Figure 3. Number and types of reports at the Cardiovas
of reports, 3309).
968 The Journal of Thoracic and Cardiovascular Surgery ● Mayimpair the receptor function and Ca release, jeopardizing
the electrical stability during effort.11 One might wonder
whether this infinitesimal gene sequence change might be
enough to deserve the name of congenital heart disease,
namely cardiac structural defect present at birth. Most prob-
ably, with the advent of molecular genetics, the definition of
congenital disease will change to include not only structural
but also gene defects present at birth.
efects with a left-to-right shunt. Note the winter-tree
am.








LDeath is an unavoidable outcome of human life, and
there will always be a need for autopsy, whether clinical or
forensic. The anatomy theater will continue to be an essen-
Figure 4. Pinpoint mutation of ryanodine receptor 2 in a family
with sudden death. Mutation of the base adenine into guanine
accounted for amino acid substitution from tyrosine into cysteine.
NoA, No arrhythmias; PPVC, polymorphous premature ventricular
complex; SD, sudden death; open symbols, unaffected; filled
symbols, affected; gray symbols, unknown. *Mutation carrier.
(Reprinted from the Journal of the American College of Cardiol-
ogy, vol 40, Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento
L, Tiso N, et al. Screening for Ryanodine Receptor Type 2 Muta-
tions in Families With Effort-Induced Polymorphic Ventricular
Arrhythmias and Sudden Death: Early Diagnosis of Asymptomatic
Carriers. p. 341-9, © 2002, with permission from The American
College of Cardiology Foundation.)tial laboratory of cardiovascular pathology. However, it is
The Journal of Thoracibecoming more and more evident that the ability to interpret
the morphologic alterations should be based on a solid
clinical and biologic background. The pathologist will never
be alone and powerless, as he was in the past, witnessing the
defeat of medicine in the silence of the mortuary. The
interdisciplinary approach to diagnosis, therapy, and pre-
vention of cardiovascular diseases will place the cardiovas-
cular pathologist working in a team with the cardiologist
and cardiac surgeon on the one hand and the geneticist and
molecular biologist on the other. Today, a wide spectrum of
diagnostic tools is at the disposal of the pathologist, and
some of them avoid the traditional microscope. They make
our jobs more useful, and the cardiovascular pathologist’s
career can be intellectually and professionally appealing to
the young generation of doctors to become protagonists in
the fight against heart disease. The strategic position of
cardiovascular pathologist, between the bench and the bed-
side, allows him or her to play a significant role in the study
of cardiovascular disease.
It is time for cardiovascular pathology to move on.2,3 The
extraordinary technologic breakthroughs in molecular biol-
ogy, including microarrays and proteomics, provide excit-
ing opportunities for investigating the causes besides the
substrates of the diseases.
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